By Helgi Library - May 21, 2023
Lekarna.cz made a net profit of CZK 47.4 mil with revenues of CZK 1,610 mil in 2021, up by 45.5% and up by 26.6%, r...
By Helgi Library - May 21, 2023
Lekarna.cz made a net profit of CZK 47.4 mil with revenues of CZK 1,610 mil in 2021, up by 45.5% and up by 26.6%, r...
By Helgi Library - May 21, 2023
Lekarna.cz employed 130 employees in 2021, up 26.2% compared to the previous year. Historically, between 2010 and 2021,...
| Profit Statement | 2019 | 2020 | 2021 | |
| Sales | CZK mil | 720 | 1,272 | 1,610 |
| Gross Profit | CZK mil | 71.2 | 118 | 147 |
| EBITDA | CZK mil | 16.9 | 46.8 | 65.8 |
| EBIT | CZK mil | 10.9 | 40.4 | 60.4 |
| Financing Cost | CZK mil | 1.21 | 0.365 | 0.299 |
| Pre-Tax Profit | CZK mil | 8.23 | 40.7 | 59.4 |
| Net Profit | CZK mil | 7.44 | 32.6 | 47.4 |
| Balance Sheet | 2019 | 2020 | 2021 | |
| Total Assets | CZK mil | 160 | 263 | 333 |
| Non-Current Assets | CZK mil | 17.9 | 30.8 | 51.3 |
| Current Assets | CZK mil | 139 | 226 | 272 |
| Working Capital | CZK mil | 24.3 | 35.4 | 19.1 |
| Shareholders' Equity | CZK mil | 31.1 | 63.1 | 105 |
| Liabilities | CZK mil | 129 | 199 | 228 |
| Total Debt | CZK mil | 32.9 | 32.8 | 32.5 |
| Net Debt | CZK mil | 1.11 | -24.0 | -50.5 |
| Ratios | 2019 | 2020 | 2021 | |
| ROE | % | 27.3 | 69.2 | 56.3 |
| ROCE | % | 14.4 | 60.1 | 69.5 |
| Gross Margin | % | 9.88 | 9.31 | 9.14 |
| EBITDA Margin | % | 2.35 | 3.68 | 4.09 |
| EBIT Margin | % | 1.51 | 3.18 | 3.75 |
| Net Margin | % | 1.03 | 2.56 | 2.95 |
| Net Debt/EBITDA | 0.066 | -0.513 | -0.767 | |
| Net Debt/Equity | % | 3.58 | -38.1 | -47.9 |
| Cost of Financing | % | 2.76 | 1.11 | 0.916 |
| Cash Flow | 2019 | 2020 | 2021 | |
| Total Cash From Operations | CZK mil | 26.6 | 44.4 | 52.3 |
| Total Cash From Investing | CZK mil | 0.401 | -19.2 | -25.9 |
| Total Cash From Financing | CZK mil | -22.2 | -0.089 | -0.341 |
| Net Change In Cash | CZK mil | 4.84 | 25.1 | 26.1 |
| Cash Conversion Cycle | days | 9.35 | 7.23 | 1.55 |
| Cash Earnings | CZK mil | 13.5 | 39.0 | 52.8 |
| Free Cash Flow | CZK mil | 27.0 | 25.1 | 26.5 |
Get all company financials in excel:
| overview | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
| income statement | |||||||||||||||||
| Sales | CZK mil | 474 | 522 | 510 | 519 | 720 | |||||||||||
| Gross Profit | CZK mil | 57.6 | 56.8 | 51.5 | 48.3 | 71.2 | |||||||||||
| EBIT | CZK mil | 14.6 | 7.11 | 4.03 | -5.56 | 10.9 | |||||||||||
| Net Profit | CZK mil | 10.5 | 3.24 | 1.83 | -8.17 | 7.44 | |||||||||||
| ROE | % | ... | 14.3 | 2.59 | 2.33 | -29.5 | 27.3 | ||||||||||
| EBIT Margin | % | 3.09 | 1.36 | 0.789 | -1.07 | 1.51 | |||||||||||
| Net Margin | % | 2.21 | 0.620 | 0.359 | -1.57 | 1.03 | |||||||||||
| Employees | ... | ... | ... | ... | 86.0 | 83.6 | 90.0 | 92.0 | 87.0 | ||||||||
| balance sheet | |||||||||||||||||
| Total Assets | CZK mil | 125 | 125 | 138 | 140 | 160 | |||||||||||
| Non-Current Assets | CZK mil | 8.64 | 11.1 | 12.2 | 23.3 | 17.9 | |||||||||||
| Current Assets | CZK mil | 116 | 109 | 120 | 113 | 139 | |||||||||||
| Shareholders' Equity | CZK mil | 125 | 125 | 31.8 | 23.5 | 31.1 | |||||||||||
| Liabilities | CZK mil | 0 | 0 | 106 | 116 | 129 | |||||||||||
| Non-Current Liabilities | CZK mil | 0 | 0 | 0 | 7.68 | 5.43 | |||||||||||
| Current Liabilities | CZK mil | 86.4 | 79.1 | 91.0 | 102 | 115 | |||||||||||
| Net Debt/EBITDA | 0.115 | 0.754 | 4.10 | -17.7 | 0.066 | ||||||||||||
| Net Debt/Equity | % | 1.42 | 5.10 | 78.4 | 118 | 3.58 | |||||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | ... | 2.72 | 1.54 | 1.28 | 2.28 | 2.76 | |||||
| cash flow | |||||||||||||||||
| Total Cash From Operations | CZK mil | ... | 3.34 | -0.562 | -13.0 | 4.11 | 26.6 | ||||||||||
| Total Cash From Investing | CZK mil | ... | -2.01 | -3.75 | 0.109 | -3.86 | 0.401 | ||||||||||
| Total Cash From Financing | CZK mil | ... | 21.1 | 0.201 | 11.7 | 2.60 | -22.2 | ||||||||||
| Net Change In Cash | CZK mil | ... | 22.4 | -4.11 | -1.11 | 2.85 | 4.84 |
| income statement | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
| income statement | |||||||||||||||||
| Sales | CZK mil | 474 | 522 | 510 | 519 | 720 | |||||||||||
| Cost of Goods & Services | CZK mil | 416 | 465 | 459 | 470 | 649 | |||||||||||
| Gross Profit | CZK mil | 57.6 | 56.8 | 51.5 | 48.3 | 71.2 | |||||||||||
| Staff Cost | CZK mil | 45.3 | 44.6 | 52.2 | 51.4 | 50.9 | |||||||||||
| EBITDA | CZK mil | 15.4 | 8.46 | 6.09 | -1.57 | 16.9 | |||||||||||
| Depreciation | CZK mil | 0.770 | 1.35 | 2.06 | 3.99 | 6.06 | |||||||||||
| EBIT | CZK mil | 14.6 | 7.11 | 4.03 | -5.56 | 10.9 | |||||||||||
| Net Financing Cost | CZK mil | 1.43 | 2.29 | -2.04 | 2.01 | 2.66 | |||||||||||
| Financing Cost | CZK mil | 0.559 | 0.483 | 0.517 | 1.18 | 1.21 | |||||||||||
| Financing Income | CZK mil | 0.207 | 0.080 | 0.267 | 0.168 | 0.176 | |||||||||||
| FX (Gain) Loss | CZK mil | 1.08 | 1.89 | -2.29 | 0.994 | 1.63 | |||||||||||
| Extraordinary Cost | CZK mil | 0 | 0 | 4.07 | 0 | 0 | |||||||||||
| Pre-Tax Profit | CZK mil | 13.2 | 4.82 | 1.99 | -7.56 | 8.23 | |||||||||||
| Tax | CZK mil | 2.73 | 1.59 | 0.159 | 0.608 | 0.791 | |||||||||||
| Minorities | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Net Profit | CZK mil | 10.5 | 3.24 | 1.83 | -8.17 | 7.44 | |||||||||||
| Net Profit Avail. to Common | CZK mil | 10.5 | 3.24 | 1.83 | -8.17 | 7.44 | |||||||||||
| growth rates | |||||||||||||||||
| Total Revenue Growth | % | ... | -13.7 | 10.1 | -2.19 | 1.64 | 38.9 | ||||||||||
| Staff Cost Growth | % | ... | -29.3 | -1.57 | 17.1 | -1.67 | -0.820 | ||||||||||
| EBITDA Growth | % | ... | -200 | -45.1 | -28.0 | -126 | -1,182 | ||||||||||
| EBIT Growth | % | ... | -188 | -51.4 | -43.4 | -238 | -296 | ||||||||||
| Pre-Tax Profit Growth | % | ... | -383 | -63.5 | -58.7 | -480 | -209 | ||||||||||
| Net Profit Growth | % | ... | -306 | -69.1 | -43.4 | -546 | -191 | ||||||||||
| ratios | |||||||||||||||||
| ROE | % | ... | 14.3 | 2.59 | 2.33 | -29.5 | 27.3 | ||||||||||
| ROA | % | ... | 9.89 | 2.59 | 1.39 | -5.89 | 4.97 | ||||||||||
| ROCE | % | ... | 36.3 | 9.89 | 4.25 | -14.7 | 14.4 | ||||||||||
| Gross Margin | % | 12.2 | 10.9 | 10.1 | 9.31 | 9.88 | |||||||||||
| EBITDA Margin | % | 3.25 | 1.62 | 1.19 | -0.302 | 2.35 | |||||||||||
| EBIT Margin | % | 3.09 | 1.36 | 0.789 | -1.07 | 1.51 | |||||||||||
| Net Margin | % | 2.21 | 0.620 | 0.359 | -1.57 | 1.03 | |||||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | ... | 2.72 | 1.54 | 1.28 | 2.28 | 2.76 | |||||
| Net Debt/EBITDA | 0.115 | 0.754 | 4.10 | -17.7 | 0.066 |
| balance sheet | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
| balance sheet | |||||||||||||||||
| Cash & Cash Equivalents | CZK mil | 29.3 | 25.2 | 24.0 | 26.9 | 31.8 | |||||||||||
| Receivables | CZK mil | 43.6 | 46.2 | 49.3 | 61.3 | 77.4 | |||||||||||
| Inventories | CZK mil | 23.1 | 19.3 | 30.6 | 24.3 | 29.9 | |||||||||||
| Current Assets | CZK mil | 116 | 109 | 120 | 113 | 139 | |||||||||||
| Property, Plant & Equipment | CZK mil | 1.81 | 0.878 | 1.34 | 10.6 | 9.16 | |||||||||||
| LT Investments & Receivables | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Intangible Assets | CZK mil | 4.48 | 7.48 | 9.03 | 10.4 | 6.32 | |||||||||||
| Goodwill | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Non-Current Assets | CZK mil | 8.64 | 11.1 | 12.2 | 23.3 | 17.9 | |||||||||||
| Total Assets | CZK mil | 125 | 125 | 138 | 140 | 160 | |||||||||||
| Trade Payables | CZK mil | 46.0 | 40.5 | 42.0 | 47.6 | 83.0 | |||||||||||
| Short-Term Debt | CZK mil | 31.1 | 31.6 | 49.0 | 46.9 | 27.5 | |||||||||||
| Other ST Liabilities | CZK mil | 9.30 | 7.02 | -0.014 | 7.70 | 4.99 | |||||||||||
| Current Liabilities | CZK mil | 86.4 | 79.1 | 91.0 | 102 | 115 | |||||||||||
| Long-Term Debt | CZK mil | 0 | 0 | 0 | 7.68 | 5.43 | |||||||||||
| Other LT Liabilities | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Non-Current Liabilities | CZK mil | 0 | 0 | 0 | 7.68 | 5.43 | |||||||||||
| Liabilities | CZK mil | 0 | 0 | 106 | 116 | 129 | |||||||||||
| Equity Before Minority Interest | CZK mil | 125 | 125 | 31.8 | 23.5 | 31.1 | |||||||||||
| Minority Interest | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||||
| Equity | CZK mil | 125 | 125 | 31.8 | 23.5 | 31.1 | |||||||||||
| growth rates | |||||||||||||||||
| Total Asset Growth | % | ... | 44.2 | 0.097 | 9.99 | 1.36 | 14.6 | ||||||||||
| Shareholders' Equity Growth | % | ... | 487 | 0.097 | -74.6 | -26.1 | 32.2 | ||||||||||
| Net Debt Growth | % | ... | -42.7 | 259 | 291 | 10.9 | -96.0 | ||||||||||
| Total Debt Growth | % | ... | ... | ... | ... | ... | ... | ... | 211 | 1.58 | 55.1 | 11.5 | -39.8 | ||||
| ratios | |||||||||||||||||
| Total Debt | CZK mil | 31.1 | 31.6 | 49.0 | 54.6 | 32.9 | |||||||||||
| Net Debt | CZK mil | 1.78 | 6.38 | 25.0 | 27.7 | 1.11 | |||||||||||
| Working Capital | CZK mil | 20.7 | 24.9 | 37.9 | 38.0 | 24.3 | |||||||||||
| Capital Employed | CZK mil | 29.4 | 36.0 | 50.2 | 61.3 | 42.2 | |||||||||||
| Net Debt/Equity | % | 1.42 | 5.10 | 78.4 | 118 | 3.58 | |||||||||||
| Current Ratio | 1.34 | 1.38 | 1.32 | 1.10 | 1.20 | ||||||||||||
| Quick Ratio | 0.844 | 0.902 | 0.806 | 0.863 | 0.946 |
| cash flow | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
| cash flow | |||||||||||||||||
| Net Profit | CZK mil | 10.5 | 3.24 | 1.83 | -8.17 | 7.44 | |||||||||||
| Depreciation | CZK mil | 0.770 | 1.35 | 2.06 | 3.99 | 6.06 | |||||||||||
| Non-Cash Items | CZK mil | ... | -8.04 | -0.962 | -3.83 | 8.38 | -0.663 | ||||||||||
| Change in Working Capital | CZK mil | ... | 0.141 | -4.19 | -13.0 | -0.096 | 13.8 | ||||||||||
| Total Cash From Operations | CZK mil | ... | 3.34 | -0.562 | -13.0 | 4.11 | 26.6 | ||||||||||
| Capital Expenditures | CZK mil | ... | -2.01 | -3.85 | -4.97 | -1.69 | 0.220 | ||||||||||
| Other Investing Activities | CZK mil | ... | 0 | 0.099 | 5.08 | -2.16 | 0.181 | ||||||||||
| Total Cash From Investing | CZK mil | ... | -2.01 | -3.75 | 0.109 | -3.86 | 0.401 | ||||||||||
| Dividends Paid | CZK mil | ... | 0 | 0 | -5.42 | -0.001 | 0 | ||||||||||
| Issuance Of Shares | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Issuance Of Debt | CZK mil | ... | 21.1 | 0.490 | 17.2 | 2.60 | -22.2 | ||||||||||
| Total Cash From Financing | CZK mil | ... | 21.1 | 0.201 | 11.7 | 2.60 | -22.2 | ||||||||||
| Effect of FX Rates | CZK mil | ... | 0 | ... | 0 | 0 | 0 | ||||||||||
| Net Change In Cash | CZK mil | ... | 22.4 | -4.11 | -1.11 | 2.85 | 4.84 | ||||||||||
| ratios | |||||||||||||||||
| Days Sales Outstanding | days | 33.6 | 32.3 | 35.3 | 43.1 | 39.2 | |||||||||||
| Days Sales Of Inventory | days | 20.3 | 15.1 | 24.4 | 18.9 | 16.8 | |||||||||||
| Days Payable Outstanding | days | 40.3 | 31.8 | 33.4 | 36.9 | 46.7 | |||||||||||
| Cash Conversion Cycle | days | 13.5 | 15.6 | 26.2 | 25.1 | 9.35 | |||||||||||
| Cash Earnings | CZK mil | 11.2 | 4.59 | 3.90 | -4.18 | 13.5 | |||||||||||
| Free Cash Flow | CZK mil | ... | 1.33 | -4.31 | -12.8 | 0.249 | 27.0 | ||||||||||
| Capital Expenditures (As % of Sales) | % | ... | 0.425 | 0.738 | 0.973 | 0.326 | -0.031 |
| other ratios | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
| Employees | ... | ... | ... | ... | 86.0 | 83.6 | 90.0 | 92.0 | 87.0 | ||||||||
| Cost Per Employee | USD per month | ... | ... | ... | ... | 1,840 | 1,763 | 2,061 | 2,126 | 2,164 | |||||||
| Cost Per Employee (Local Currency) | CZK per month | ... | ... | ... | ... | 43,913 | 44,471 | 48,355 | 46,515 | 48,785 | |||||||
| Material & Energy (As % of Sales) | % | 72.2 | 73.3 | 74.4 | 74.8 | 78.0 | |||||||||||
| Services (As % of Sales) | % | 15.7 | 15.8 | 15.6 | 15.9 | 12.2 | |||||||||||
| Staff Cost (As % of Sales) | % | 9.56 | 8.55 | 10.2 | 9.90 | 7.07 | |||||||||||
| Effective Tax Rate | % | 20.7 | 32.9 | 7.99 | -8.04 | 9.61 | |||||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | 10.4 | 7.72 | 3.56 | 0.771 | 5.59 | ||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 18.7 | 13.2 | 9.41 | 11.2 |
Get all company financials in excel:
By Helgi Library - May 21, 2023
Lekarna.cz employed 130 employees in 2021, up 26.2% compared to the previous year. Historically, between 2010 and 2021, the firm's workforce hit a high of 130 employees in 2021 and a low of 77.0 employees in 2010. Average personnel cost stood at USD ...
By Helgi Library - May 21, 2023
Lekarna.cz invested a total of CZK 25.9 mil in 2021, up 34.6% compared to the previous year. Historically, between 2007 - 2021, the company's investments stood at a high of CZK 25.9 mil in 2021 and a low of CZK -7.92 mil in 2014. As a...
By Helgi Library - May 21, 2023
Lekarna.cz invested a total of CZK 25.9 mil in 2021, up 34.6% compared to the previous year. Historically, between 2007 - 2021, the company's investments stood at a high of CZK 25.9 mil in 2021 and a low of CZK -7.92 mil in 2014. As a...
By Helgi Library - May 21, 2023
Lekarna.cz made a net profit of CZK 47.4 mil in 2021, up 45.5% compared to the previous year. Historically, between 2006 and 2021, the company's net profit reached a high of CZK 47.4 mil in 2021 and a low of CZK -15.4 mil in 2013. The result implies a ret...
By Helgi Library - May 21, 2023
Lekarna.cz made a net profit of CZK 47.4 mil in 2021, up 45.5% compared to the previous year. Historically, between 2006 and 2021, the company's net profit reached a high of CZK 47.4 mil in 2021 and a low of CZK -15.4 mil in 2013. The result implies a ret...
By Helgi Library - May 21, 2023
Lekarna.cz made a net profit of CZK 47.4 mil with revenues of CZK 1,610 mil in 2021, up by 45.5% and up by 26.6%, respectively, compared to the previous year. This translates into a net margin of 2.95%. Historically, between 2006 and 2021, the firmâ...
By Helgi Library - May 21, 2023
Lekarna.cz made a net profit of CZK 47.4 mil with revenues of CZK 1,610 mil in 2021, up by 45.5% and up by 26.6%, respectively, compared to the previous year. This translates into a net margin of 2.95%. Historically, between 2006 and 2021, the firmâ...
By Helgi Library - May 21, 2023
Lekarna.cz's net debt stood at CZK -50.5 mil and accounted for -47.9% of equity at the end of 2021. The ratio is down 9.85 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 118% in 2018 and a low of ...
By Helgi Library - May 21, 2023
Lekarna.cz's net debt stood at CZK -50.5 mil and accounted for -47.9% of equity at the end of 2021. The ratio is down 9.85 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 118% in 2018 and a low of ...
Lekarna.cz is a Czech-based online pharmacy owned by Pears Health Cyber. The Company was set up by VladimĂr Finsterle in 1999 as an information portal about medications. In 2003, the Company turned into an e-shop and become the first online pharmacy in the Czech Republic.
Lekarna.cz has been growing its sales by 25.3% a year on average in the last 5 years. EBITDA has grown on average by 50.7% a year during that time to total of CZK 65.8 mil in 2021, or 4.09% of sales. That’s compared to 2.20% average margin seen in last five years.
The company netted CZK 47.4 mil in 2021 implying ROE of 56.3% and ROCE of 69.5%. Again, the average figures were 25.1% and 26.7%, respectively when looking at the previous 5 years.
Lekarna.cz’s net debt amounted to CZK -50.5 mil at the end of 2021, or -47.9% of equity. When compared to EBITDA, net debt was -0.767x, up when compared to average of -2.96x seen in the last 5 years.
Helgi Library 
